PoZibio® Named Finalist in NutraIngredients-USA Awards: Ingredient of the Year: Microbiome Modulation
Sabinsa, the multi-national health science company founded 36 years ago by the late Dr. Muhammed Majeed, announces that PoZibio®, its innovative postbiotic ingredient, has been named a finalist for ‘Ingredient of the Year: Microbiome Modulation – in association with Probiota Americas’ at the prestigious NutraIngredients-USA Awards from William Reed.
Sabinsa Global CEO Shaheen Majeed Chairs ‘Global Innovation & Intellectual Property (IP) Summit’
Shaheen Majeed, Global CEO and Managing Director of Sami-Sabinsa Group and Vice Chairman of the CII National Committee on IP, chaired the 15th Global Innovation & Intellectual Property Summit held on 29 April 2025 by the Confederation of Indian Industry (CII), at Hotel Lalit, New Delhi.
Dr. Alphons Philips Joins Sabinsa as Director-Scientific Affairs
Dr. Philips brings extensive industry experience in drug safety, consumer product safety, cosmeceuticals, and nutraceuticals. He is an accomplished scientific affairs leader with deep expertise in clinical research, drug safety, consumer product safety, cosmetovigilance, regulatory data science, and claims substantiation across the nutraceutical and functional food industries.
Sabinsa Acquires Established Ayurvedic Brand Nature’s Formulary, Names PK Davé CEO of Sabinsa’s Consumer Goods Division
Sabinsa, the multi-national health science company known for providing sustainable, natural, well-researched ingredients, has acquired the respected Ayurvedic products brand Nature’s Formulary, and named that company’s founder and president as CEO of Sabinsa’s Consumer Goods Division, focusing on wellness products to include the America’s Finest, Inc (AFI), Nature’s Formulary, and Sanutra Wellness brands.
Sabinsa’s Global CEO Shaheen Majeed Receives Honorary Doctorate from the University of Mysore
Sabinsa, the multi-national health science company known for providing sustainable, natural, well-researched ingredients, is pleased to share the news that the venerated University of Mysore conferred an honorary doctorate upon Shaheen Majeed, Global CEO and Managing Director of Sabinsa. The Honoris Causa (D.Litt.) of the University of Mysore in Research and Innovation was conferred at the University’s 105th Annual Convocation at the University in Mysuru, India on January 18, 2025.
Sabinsa’s Kunigal Manufacturing Facility Recognized for Environmental Sustainability by the Karnataka State Pollution Control Board
Sabinsa, the multi-national health science company known for providing sustainable natural, well-researched ingredients, was honored by India’s Karnataka State Pollution Control Board (KSPCB) with the Environmental Sustainability award for “outstanding performance in environment, health, and safety” of the company’s Sami Kunigal manufacturing facility.
UNPA Honors Sami-Sabinsa’s Global CEO Shaheen Majeed and Late Founder Dr. Muhammed Majeed
Sabinsa, the multi-national health science company known for providing sustainable natural, well-researched ingredients, received special recognition from the United Natural Products Alliance (UNPA) on Wednesday, October 30, 2024 at the SupplySide West UNPA Member Meeting.
Sami-Sabinsa Group Welcomes Dr. K Srinivasa Reddy as Director of Quality & Regulatory
Sabinsa, the multi-national health science company known for providing sustainable natural, well-researched ingredients, announces Dr. K Srinivasa Reddy as Sami-Sabinsa Group Director of Quality & Regulatory.
Shaheen Majeed, Sabinsa Global CEO & Managing Director, Elected as Vice Chairman of the CII National Committee on Intellectual Property Rights
Shaheen Majeed, Global CEO & Managing Director of Sami-Sabinsa Group, has been elected as Vice Chairman of the Confederation of Indian Industry National Committee on Intellectual Property Rights (2024-25).
Sami-Sabinsa Group Explores Collaboration with Key Universities for Cooperative Research and Contract Cultivation Program Expansion
Sabinsa, the multi-national health science company known for providing sustainable natural, well-researched ingredients, has taken steps to deepen ties with respected scientific research institutions.
Dr. Majeed Foundation, CSR Arm of Sami-Sabinsa Group Disburses USD $30,000 in Scholarships
The Dr. Majeed Foundation, the CSR arm of the multinational health and life sciences company Sami-Sabinsa Group created by the late founder of the company, Dr. Muhammed Majeed, recently awarded USD $30,000 in scholarships to 130 meritorious students from economically disadvantaged families in the State of Karnataka, India as part of ongoing philanthropic programs. The Dr. Majeed Foundation partnered with The Akshaya Patra Foundation to identify deserving students pursing secondary school and higher education to receive the financial assistance.
Dr. Anju Majeed appointed Co-Chair of ASSOCHAM Karnataka State Development Council
Dr. Anju Majeed, the Sami-Sabinsa Group Executive Chairperson, has been appointed Co-Chair of the Associated Chambers of Commerce and Industry of India (ASSOCHAM) Karnataka State Development Council for the year 2024-25. ASSOCHAM plays a significant role in shaping the trade, commerce, and industrial environment of India, including in the development of the herb industry.
Dr. Devaraj Reddy Joins the Sami-Sabinsa Group as Chief Operating Officer
The Sami-Sabinsa Group, a global leader in the nutraceutical and cosmeceutical industries, is delighted to announce the addition of Dr. Devaraj Reddy to the management team as Chief Operating Officer.
USP Acknowledges Sami-Sabinsa for Reference Standards Contributions
Sabinsa, a global leader in the nutraceutical and cosmeceutical industries, was recognized by the United States Pharmacopeia (USP) for providing candidate documentary and reference standards that assisted USP in reaching important milestones in 2023. USP’s Certificate of Appreciation also acknowledged Sabinsa’s outstanding contributions towards global public health though the advancement of USP standards.
Sami-Sabinsa Group’s Hassan Unit 1 Facility Certified as Meeting NSF cGMP Requirements
The Sami-Sabinsa Group’s Hassan Unit 1 facility, M/s. Sami Nutraceuticals Private, has been assessed, and compliance with the NSF GMP Registration Program Requirements of NSF/ANSI 173, Section 8 (which includes FSMA and cGMPs (21 CFR Part 111, 21 CFR Part 117)) has been confirmed, with the certificate issued by NSF on June 19, 2024.
Sabinsa Founder Dr. Muhammed Majeed Honored with Times Business Awards Lifetime Achievement Award (Posthumous)
Sabinsa’s founder, the late Dr. Muhammed Majeed, was honored with the Times Business Awards Lifetime Achievement Award (Posthumous) for his “exemplary contributions to Nutraceuticals and Cosmeceuticals, and Philanthropy” in a ceremony in Bengaluru, India on June 21, 2024. Dr. Anju Majeed, Sami-Sabinsa Group Executive Chairperson, and Mr. Shaheen Majeed, Global Managing Director & CEO of Sami-Sabinsa Group, received the award honoring their father.
Sami-Sabinsa Group Mourns Passing of Dr. Nagabhushanam Kalyanam Ph.D., President R&D
Dr. Anju Majeed, Sami-Sabinsa Group Executive Chairperson, Shaheen Majeed, Sami-Sabinsa Group Global Managing Director & Chief Executive Officer, and the entire Sami-Sabinsa Group family mourns the sudden passing of President R&D Nagabhushanam Kalyanam, Ph.D. at age 74. Dr. Kalyanam was a dedicated scientific advisor to Dr. Muhammed Majeed, Founder and Chairman, of Sami-Sabinsa Group in the development of the company’s various high-quality ingredients until Dr. Majeed’s passing in March.
Sami-Sabinsa Group Elevates Dr. Anju Majeed to Group Executive Chairperson, Appoints Mr. Shaheen Majeed as the new Global Managing Director & CEO
Dr. Anju Majeed, Sami-Sabinsa Group Executive Chairperson, Shaheen Majeed, Sami-Sabinsa Group Global Managing Director & Chief Executive Officer, and the entire Sami-Sabinsa Group family mourns the sudden passing of President R&D Nagabhushanam Kalyanam, Ph.D. at age 74. Dr. Kalyanam was a dedicated scientific advisor to Dr. Muhammed Majeed, Founder and Chairman, of Sami-Sabinsa Group in the development of the company’s various high-quality ingredients until Dr. Majeed’s passing in March.
Dr. Muhammed Majeed (September 25, 1948 – March 13, 2024) Founder and Chairman, Sami-Sabinsa Group
As a researcher, scientist, entrepreneur, and business leader, Dr. Majeed pioneered the development of standardized herbal extracts from India’s Ayurvedic plants and created a global market for them. He founded and, for 36 years, led the Sami-Sabinsa Group as it became a leading multinational health & life sciences company.
Sami-Sabinsa Celebrates 35th Anniversary
Sabinsa, the official Curcumin Sponsor of SupplySide West, will highlight several new branded ingredients from its ever-growing portfolio in booth #4555 at the show, October 27-28, 2021, at the Mandalay Bay Convention Center, Las Vegas, NV.
Sabinsa to Introduce New Products and the Most Recent Book on Ashwagandha by Dr. Muhammed Majeed at SupplySide West
Sabinsa, the official Curcumin Sponsor of SupplySide West, will highlight several new branded ingredients from its ever-growing portfolio in booth #4555 at the show, October 27-28, 2021, at the Mandalay Bay Convention Center, Las Vegas, NV.
Sami-Sabinsa to Showcase New Products, Host Event at Vitafoods Europe
Sami-Sabinsa Europe will feature new and popular products as well as host an event at the Vitafoods Europe tradeshow to be held 05 – 07 October, 2021 in Palexpo, Geneva.
Sabinsa’s Postbiotic LactoSporin® Wins 1st Place in NIE Awards
Sabinsa’s LactoSporin® received the first-place award in 2021 Nutrition Industry Executive (NIE) Awards in the Personal Care / Cosmetics category…
Sabinsa Names Dr. Umar Jan as President of European Operations
Sabinsa’s founder and chairman, Dr. Muhammed Majeed, announced today the promotion of Dr. Umar Jan to President of European Operations…
Sabinsa Expands UK and EU Footprint with New Staff
Sabinsa has opened two new satellite offices in the UK and in Spain to support customers in Europe. The Spanish office will service Spain, Portugal, the Iberian Peninsula, Southern France, and Northwestern Africa….
Sabinsa Reaches Intellectual Property Milestone with over 300 Patents Granted
Sabinsa’s intellectual property portfolio now includes 308 separate patents granted across the world. The most recent patents granted include several from Australia, Canada, Europe, and the USA. Sabinsa’s patent portfolio includes composition, use and process patents…
Sabinsa Cosmeceutical Ingredients COSMOS Approved: Cococin™, Saberry®, and Nigellin® Amber
Sabinsa has successfully completed the audit for several of its natural cosmetic ingredients as conforming to COSMOS standards, verified by Ecocert Greenlife: Cococin™ (Cocos nucifera liquid Endosperm), Saberry® (Emblica officinalis fruit extract) and Nigellin® Amber (Black seed extract)…
Research Published on Sabinsa’s Curcumin C3 Complex® / BioPerine® Combination as Adjuvant Therapy in COVID-19 Patients
Sabinsa’s flagship combination product, Curcumin C3 Complex® with BioPerine® (525mg/2.5 mg twice a day, 14 days), was used as adjuvant therapy for COVID-19 in a double-blind, randomized controlled clinical trial conducted on COVID-19 patients in India, where the wide-spread virus infection has strained the healthcare system…
Court Orders Prakruti to Pay over $1 Million in Fees and Costs to Sami-Sabinsa as a Sanction for Discovery Abuses in Litigation
Sami-Sabinsa Group Limited, the world leader in Curcumin for the dietary supplements industry, has been awarded more than $1 Million in attorney’s fees and costs against Prakruti Products…
Sabinsa Founder Dr. Muhammed Majeed Named Father of Indian Nutraceuticals Industry by ASSOCHAM
Dr. Muhammed Majeed, founder of the Sami-Sabinsa Group, was named the Father of Indian Nutraceuticals Industry with an honorary award presented on the occasion of ASSOCHAM’s virtual conference entitled Efficacy of Herbal Nutraceuticals: Stimulating the New Lifestyle…
New Research Published on Sami-Sabinsa’s Curcumin C3 Reduct® Supports Efficacy as an Oral Care Ingredient
New research has recently been published that builds upon evidence from a previous trial investigating the potential of Sami-Sabinsa’s Curcumin C3 Reduct® ingredient in oral care applications…
Sabinsa Top Scientist Gives Presentation to U.S. FDA
Dr. Kalyanam Nagabhushanam, President (R&D), Sabinsa Corporation presented, at the invitation of FDA, a seminar on December 10, 2020 to a group of US FDA scientists as part of the CDER Botanical Drug Seminar Series (BDSS)…